Radius Raises $43 Million Series B After Withdrawn IPO
4/25/2013 6:37:34 AM
More...
|
Radius to Present at Biotechnology Industry Organization (BIO) Business Forum®
4/18/2013 11:17:03 AM
More...
|
Radius Completes Enrollment for Phase 3 Study of Bone-Building Osteoporosis Drug
3/12/2013 9:06:54 AM
More...
|
Radius to Present at Cowen and Company 33rd Annual Health Care Conference in Boston
2/27/2013 10:02:11 AM
More...
|
Radius to Present at Biotechnology Industry Organization (BIO) CEO & Investor in New York
2/11/2013 9:14:02 AM
More...
|
Radius Provides Update on Pivotal Phase 3 Program for BA058-SC Injection
1/7/2013 9:43:24 AM
More...
|
Radius Completes Enrollment for Phase 2 Study of BA058-Transdermal Patch for Treatment of Postmenopausal Osteoporosis
1/4/2013 8:55:06 AM
More...
|
Radius, 3M Drug Delivery Systems Announce Exclusive Agreement for Development, Commercialization of Transdermal Delivery of BA058 for Osteoporosis
12/21/2012 9:04:13 AM
More...
|
Radius Announces Upcoming Scientific Presentations at the American Society for Bone and Mineral Research 2012 Annual Meeting
10/15/2012 9:15:02 AM
More...
|
Radius Initiates Phase 2 Study of BA058-Transdermal for the Treatment of Postmenopausal Osteoporosis
9/27/2012 8:59:05 AM
More...
|
|